A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.

Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the…